Featured Researchers

Dr. Robert Bristow and Dr. Paul Boutros



The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature. Led by Drs. Robert Bristow of the Princess Margaret Cancer Centre and Paul Boutros of the Ontario Institute for Cancer Research, CPC-GENE has uncovered the full set of mutations that can occur in the most common cancer in men. By fully cataloging these mutations, the CPC-GENE team was able to create a new signature that predicts at an early stage whether a prostate cancer tumour will become aggressive or not, allowing for personalized treatment.

Dr. Robert Bristow



Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer. Funded by Prostate Cancer Canada and led by Dr. Robert Bristow of the Princess Margaret Cancer Centre in Toronto, the findings were published in Nature Communications.

Dr. John Bell


 
Thanks to the dedication and enthusiasm of Mo Bros and Mo Sistas across the country, funds raised through Movember enable Prostate Cancer Canada to select and support research that will make a big difference in the lives of everyone affected by the most common cancer in men. A recent example of this us research being undertaken by Dr. John Bell of the University of Ottawa in the area of immunotherapy. More specifically, he and a team of researchers from a number of institutions across the country are engineering cancer-killing viruses. It is your moustaches and MOVEs that continue to make life-changing work possible. Please check out the video to learn more about the difference you're making!

Dr. Paul Boutros

 

To mark Prostate Cancer Awareness Month, we wanted to highlight some of the great research taking place that has been made possible through the generosity of Canadians like the work being led by Dr. Paul Boutros. Together, we are making a difference in the lives of the 1 in 7 Canadian men who will be diagnosed with prostate cancer and their families.

For more information and support:

 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive